Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology

NCT03067506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-01-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to evaluate the feasibility and compliance with a novel method for assessing mood and cognition in participants with major depressive disorder (MDD).

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

Principal Investigators

  • Medical Director Clinical Science · Takeda

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2017-07-03
Completion
2017-07-03

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067506 on ClinicalTrials.gov